Cancer Screenings Are Available For Many, But Not Used

Cancer Screenings Are Available For Many, But Not Used
Medicaid recipients age 50 and older are falling short of national cancer screening objectives. According to a report published in the October 13 issue of Archives of Internal Medicine, only about half receive colorectal, breast, and cervical cancer screening tests that the government recommends. Cancers of the colon, breast, and cervix can be detected early and have the potential to be cured.

November Is National Alzheimer's Disease Awareness Month
Twenty five years ago, November was designated as National Alzheimer's Disease Awareness Month. At the time, fewer than 2 million Americans had Alzheimer's. Today, as many as 5.2 million Americans are living with Alzheimer's disease - 120,000 of them in Massachusetts. Alzheimer's can occur as young as age 35, and is currently the sixth leading cause of death in the country. By 2050, 11 to 16 million people will likely have Alzheimer's.

Provectus Announces First Peer-Reviewed Publication On PV-10 In "Melanoma Research"
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, announced that "Melanoma Research" has published a paper entitled, "Chemoablation of metastatic melanoma using intralesional Rose Bengal," on its website. The paper is authored by Professor John F. Thompson, M.D. and his colleagues, Professor Peter Hersey, M.D. and Eric Wachter, Ph.D.

Women Needed For Breast Cancer Prevention Trial, Manchester, England
Manchester women at high risk of developing breast cancer are being urged to take part in a pioneering research programme into the prevention of the disease. The Genesis Appeal, the UK's only charity dedicated entirely to the prevention of breast cancer, is recruiting women to take part in the International Breast Cancer Intervention Study (IBIS II).

New issue of Diabetic Hypoglycaemia discusses mortality differences in ACCORD and ADVANCE studies
Diabetic Hypoglycaemia, the influential online diabetes journal published by ESP Bioscience, leads its new issue with a topical editorial, authored by Professor Simon Heller, one of the ADVANCE investigators, and Dr Rory McCrimmon.

AACR And Pancreatic Cancer Action Network Provide Over $1.2 Million In Funds For Pancreatic Cancer Research
The American Association for Cancer Research is accepting applications for grants supporting pancreatic cancer research. The deadline for applications is November 10, 2008. The grant terms will begin on July 1, 2009. Pancreatic cancer is the fourth leading cause of cancer death in the United States.

Breakthrough Cancer Pain - Archimedes Pharma Announces First Positive Phase III Clinical Trial Results For NasalFent
Archimedes Pharma Limited, the UK based, pan-European specialty pharmaceutical company, today announces positive headline Phase III results for NasalFent®, the Company's innovative fentanyl citrate nasal spray, developed to provide fast, effective and convenient treatment for breakthrough cancer pain.